CORT

Corcept Therapeutics

Phase 2 Confirmed

relacorilant

platinum-sensitive ovarian cancer

Countdown

177days

Phase 2 readout · ~ Dec 31, 2026 estimated

What's at stake Phase 2 trial results for relacorilant in platinum-sensitive ovarian cancer are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 14h ago

“STELLA – Phase 2 trial of relacorilant plus nab-paclitaxel in 50 patients with cervical cancer to begin in coming weeks”

Add to calendar Post on X Reddit

Provenance